Stockscreener 앱 받기
8.75
3.21%
-0.29
시간 외 거래:
8.75
Olema Pharmaceuticals Inc 주식(OLMA)의 최신 뉴스
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.1%Time to Sell? - MarketBeat
H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $36 - Moomoo
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Olema Pharmaceuticals at H.C. Wainwright: pipeline bets on breast cancer By Investing.com - Investing.com Canada
Olema Pharmaceuticals (OLMA) Slips to $9.75 as Shares Sit Mid-Range Between Key LevelsGamma Squeeze - careplusvn.com
Goldman Sachs Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA) - The Globe and Mail
OLMA Maintained by Stifel -- Price Target Lowered to $30 - GuruFocus
Stifel cuts Olema Pharmaceuticals price target on trial concerns By Investing.com - Investing.com Nigeria
Why is Olema Pharmaceuticals stock sliding today? By Investing.com - Investing.com Canada
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results - Yahoo Finance
Olema Pharmaceuticals (OLMA) Shares Drop 15% After AstraZeneca B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 4.4%Here's Why - MarketBeat
Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $59 - Moomoo
Olema Pharmaceuticals, Inc. $OLMA Shares Sold by Squarepoint Ops LLC - MarketBeat
OLMA: Phase III breast cancer trials for palazestrant target over $15B in global market opportunities - TradingView
Olema Oncology at citigroup summit: palazestrant data, delays - Investing.com
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 3.5%Should You Buy? - MarketBeat
Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1'27 (NASDAQ:OLMA) - Seeking Alpha
Wellington Management Group LLP Cuts Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
OLMA Sees Early Tumor Shrinkage in Phase 1 OP-3136 Study, Stock Gains Pre-Market - Stocktwits
Readystate Asset Management LP Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Bank of New York Mellon Corp Invests $2.78 Million in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals Inc. (OLMA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals Grants Inducement Stock Options to Newly Appointed CFO Jason V. O’Byrne - Quiver Quantitative
Olema Pharmaceuticals (NASDAQ: OLMA) grants CFO 650K options expiring in 2036 - Stock Titan
Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire
Olema Pharmaceuticals Inc. (OLMA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BlackRock Inc. Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals Inc. (OLMA) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Jupiter Topco LLC Takes $88.80 Million Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Bank of America Corp DE Raises Stock Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Olema Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. OLMA Stock Forecast & Price Target - Yahoo! Finance Canada
OLMA News | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $46 - Moomoo
Olema Oncology appoints Jason O’Byrne as CFO - The Pharma Letter
OLMA Maintained by JP Morgan -- Price Target Lowered to $46.00 - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price - MarketBeat
Olema Pharmaceuticals, Inc. Announces Appointment of Jason O?Byrne to Chief Financial Officer, Effective August 11, 2026 - marketscreener.com
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46 - moomoo.com
Olema Pharmaceuticals Names Jason O'Byrne as New CFO with Comprehensive Compensation Package - Kalkine Media
Form 8K Olema Pharmaceuticals Inc For: 13 August By Investing.com - Investing.com Nigeria
HC Wainwright Brokers Decrease Earnings Estimates for OLMA - MarketBeat
Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer - The Manila Times
Olema Oncology’s New CFO Brings More Than Two Decades in Biotech - Stock Titan
Olema Pharmaceuticals Names Jason O'Byrne CFO - Yahoo Finance
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus - Moomoo
Olema stock falls 12.9% as Q2 loss widens to $63.2M on R&D spend - scanx.trade
OLMA Maintains Rating by Citigroup -- Price Target Lowered to $5 - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Lowered to $59.00 at Citigroup - MarketBeat
Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027 - TradingView
TD Cowen Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating - Moomoo
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap Down on Disappointing Earnings - MarketBeat
Olema Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $39.9, Implies 234% Upside - TradingView
OLMA Maintains Buy Rating -- Price Target Lowered to $36.00 by H - GuruFocus
H.C. Wainwright lowers Olema Pharmaceuticals price target to $36 By Investing.com - Investing.com Canada
3.06%
2.55%
자본화:
|
볼륨(24시간):